Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Otoferlin Gene-mediated Hearing Loss Natural History Study

View source ↗

Summary

Akouos, Inc. is conducting a natural history study of otoferlin gene-mediated bilateral sensorineural hearing loss, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Akouos, Inc. | Conditions: Sensorineural Hearing Loss, Bilateral | Status: RECRUITING